SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
BOULDER, Colo., June 12, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain.
- BOULDER, Colo., June 12, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and support unit, to establish the company’s first authorized site in Spain.
- As part of the agreement, Citogen will offer the 7,000-plex SomaScan® Assay and provide SomaScan data to their customers in Southern Europe supporting biological research across an array of disciplines including clinical research, population health studies and nutrigenomics.
- "Our goal is to give research centers throughout Europe access to state-of-the-art technologies available in the market,” said Longwood Group Chief Executive Officer Miguel Giralt.
- The laboratory has more than 20 years of research laboratory experience, specializing in clinical, forensic and reproductive genetics.